Cargando…
Data for iTRAQ-based quantification of the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats
The data presented in this article are related to the research article entitled “Isobarictags for relative and absolute quantitation (iTRAQ) -based proteomics for the investigation of the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats” (Yao et al., 2017) [1]. This article descri...
Autores principales: | Yao, Xiaorui, Xia, Fan, Tang, Waijiao, Xiao, Chunxin, Yang, Miaoting, Zhou, Benjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655393/ https://www.ncbi.nlm.nih.gov/pubmed/29085877 http://dx.doi.org/10.1016/j.dib.2017.10.027 |
Ejemplares similares
-
Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury
por: Xia, Fan, et al.
Publicado: (2017) -
Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease
por: Tang, Waijiao, et al.
Publicado: (2018) -
Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ
por: Yang, Miaoting, et al.
Publicado: (2020) -
Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease
por: Tang, WaiJiao, et al.
Publicado: (2015) -
Discovery of Quality Markers in Hugan Qingzhi Formula by Integrating a Lipid-Lowering Bioassay with UHPLC-QQQ-MS/MS
por: He, Fan, et al.
Publicado: (2020)